Biocon stock zooms 9% on Psoriasis drug approval…

[ad_1] Shares of Biocon popped up 9% in Tuesday's trade, January 07, to hit a level of ₹389 apiece, a level not seen since mid-September, driven by multiple positive developments. The company informed investors through…